Tuberculosis and Respiratory Diseases

The Korean Academy of Tuberculosis and Respiratory Diseases (대한결핵및호흡기학회)
권호 표지
DOI QR코드

DOI QR Code

Thrombotic Complications during Interventional Lung Assist: Case Series

  • Kim, Eun Jung (Department of Internal Medicine, Pusan National University Yangsan Hospital) ;
  • Cho, Woo Hyun (Department of Internal Medicine, Pusan National University Yangsan Hospital) ;
  • Ahn, Eun Young (Department of Internal Medicine, Pusan National University Yangsan Hospital) ;
  • Ryu, Dae Gon (Department of Internal Medicine, Pusan National University Yangsan Hospital) ;
  • Lee, Seung Eun (Department of Internal Medicine, Pusan National University Yangsan Hospital) ;
  • Jeon, Doo Soo (Department of Internal Medicine, Pusan National University Yangsan Hospital) ;
  • Kim, Yun Seong (Department of Internal Medicine, Pusan National University Yangsan Hospital) ;
  • Son, Bong Soo (Department of Cardiovascular and Thoracic Surgery, Pusan National University Yangsan Hospital) ;
  • Kim, Do Hyung (Department of Cardiovascular and Thoracic Surgery, Pusan National University Yangsan Hospital)
  • Received : 2014.05.19
  • Accepted : 2014.09.04
  • Published : 2015.01.30
Download PDF
⟨ Previous Next ⟩

Abstract

Interventional lung assist (iLA) effectively reduces $CO_2$ retention and allows protective ventilation in cases of life-threatening hypercapnia. Despite the clinical efficacy of iLA, there are a few major limitations associated with the use of this approach, such as bleeding, thrombosis, and catheter-related limb ischemia. We presented two cases in which thrombotic complications developed during iLA. We demonstrated the two possible causes of thrombotic complications during iLA; stasis due to low blood flow and inadequate anticoagulation.

Keywords

References

  1. Tao W, Brunston RL Jr, Bidani A, Pirtle P, Dy J, Cardenas VJ Jr, et al. Significant reduction in minute ventilation and peak inspiratory pressures with arteriovenous $CO_2$ removal during severe respiratory failure. Crit Care Med 1997;25:689-95. https://doi.org/10.1097/00003246-199704000-00022
  2. Liebold A, Reng CM, Philipp A, Pfeifer M, Birnbaum DE. Pumpless extracorporeal lung assist: experience with the first 20 cases. Eur J Cardiothorac Surg 2000;17:608-13. https://doi.org/10.1016/S1010-7940(00)00389-4
  3. Bein T, Weber F, Philipp A, Prasser C, Pfeifer M, Schmid FX, et al. A new pumpless extracorporeal interventional lung assist in critical hypoxemia/hypercapnia. Crit Care Med 2006;34:1372-7. https://doi.org/10.1097/01.CCM.0000215111.85483.BD
  4. Zick G, Frerichs I, Schadler D, Schmitz G, Pulletz S, Cavus E, et al. Oxygenation effect of interventional lung assist in a lavage model of acute lung injury: a prospective experimental study. Crit Care 2006;10:R56. https://doi.org/10.1186/cc4889
  5. Zimmermann M, Bein T, Arlt M, Philipp A, Rupprecht L, Mueller T, et al. Pumpless extracorporeal interventional lung assist in patients with acute respiratory distress syndrome: a prospective pilot study. Crit Care 2009;13:R10. https://doi.org/10.1186/cc7703
  6. Jayroe JB, Wang D, Deyo DJ, Alpard SK, Bidani A, Zwischenberger JB. The effect of augmented hemodynamics on blood flow during arteriovenous carbon dioxide removal. ASAIO J 2003;49:30-4. https://doi.org/10.1097/00002480-200301000-00005
  7. Cho WH, Lee K, Huh JW, Lim CM, Koh Y, Hong SB. Physiologic effect and safety of the pumpless extracorporeal interventional lung assist system in patients with acute respiratory failure: a pilot study. Artif Organs 2012;36:434-8. https://doi.org/10.1111/j.1525-1594.2011.01359.x
  8. Bein T, Zimmermann M, Philipp A, Ramming M, Sinner B, Schmid C, et al. Addition of acetylsalicylic acid to heparin for anticoagulation management during pumpless extracorporeal lung assist. ASAIO J 2011;57:164-8. https://doi.org/10.1097/MAT.0b013e318213f9e0
  9. Villaneuva GB, Danishefsky I. Evidence for a heparin-induced conformational change on antithrombin III. Biochem Biophys Res Commun 1977;74:803-9. https://doi.org/10.1016/0006-291X(77)90374-6
  10. Oliver WC. Anticoagulation and coagulation management for ECMO. Semin Cardiothorac Vasc Anesth 2009;13:154-75. https://doi.org/10.1177/1089253209347384

Cited by

  1. Extracorporeal carbon dioxide removal (ECCO2R) in respiratory deficiency and current investigations on its improvement: a review vol.20, pp.1, 2015, https://doi.org/10.1007/s10047-016-0905-x